Holen Sie sich die Stockscreener-App
18.47
0.70%
-0.13
Schlusskurs vom Vortag:
$18.60
Offen:
$18.72
24-Stunden-Volumen:
170.16K
Relative Volume:
1.12
Marktkapitalisierung:
$327.29M
Einnahmen:
$114.73M
Nettoeinkommen (Verlust:
$-140.94M
KGV:
-6.692
EPS:
-2.76
Netto-Cashflow:
$-126.18M
1W Leistung:
-5.52%
1M Leistung:
+72.94%
6M Leistung:
+47.01%
1J Leistung:
-68.47%
1-Tages-Spanne:
$17.57
$19.03
1-Wochen-Bereich:
$17.57
$20.84
52-Wochen-Spanne:
$5.85
$72.60
Outset Medical Inc Stock (OM) Company Profile
Firmenname
Outset Medical Inc
Sektor
Branche
Telefon
669-231-8200
Adresse
3052 ORCHARD DRIVE, SAN JOSE
Vergleichen Sie OM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OM
Outset Medical Inc
|
18.47 | 346.47M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
131.50 | 232.01B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.50 | 155.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
378.28 | 149.89B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
80.91 | 110.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.79 | 45.10B | 5.54B | 4.18B | 623.10M | 7.00 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Eingeleitet | BTIG Research | Buy |
| 2024-04-05 | Hochstufung | CL King | Neutral → Buy |
| 2024-01-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-08-17 | Eingeleitet | CL King | Neutral |
| 2022-11-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-07-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Eingeleitet | Cowen | Outperform |
| 2021-04-19 | Eingeleitet | Wells Fargo | Overweight |
| 2020-12-16 | Eingeleitet | Oppenheimer | Perform |
| 2020-10-12 | Eingeleitet | Barclays | Overweight |
| 2020-10-12 | Eingeleitet | BofA Securities | Buy |
| 2020-10-12 | Eingeleitet | Goldman | Buy |
| 2020-10-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-10-12 | Eingeleitet | Stifel | Buy |
Alle ansehen
Outset Medical Inc Aktie (OM) Neueste Nachrichten
Outset Medical’s SWOT analysis: stock outlook amid commercial transformation By Investing.com - Investing.com Nigeria
Outset Medical’s SWOT analysis: stock outlook amid commercial transformation - Investing.com Australia
Outset Medical shares rise on RBC price target boost By Investing.com - Investing.com South Africa
OM: Analyst Shagun Singh Raises Price Target for Outset Medical | OM Stock News - GuruFocus
Outset Medical shares rise on RBC price target boost - Investing.com
Outset Medical Inc. (OM) PT Raised to $21 at RBC Capital - StreetInsider
RBC Raises Price Target on Outset Medical to $21 From $14, Keeps Sector Perform Rating - marketscreener.com
RBC Capital Raises Price Target for Outset Medical (OM) to $21 | OM Stock News - GuruFocus
Outset Medical appoints Kevin O’Boyle to its Board - Medical Buyer
Outset Medical adds healthcare veteran to board By Investing.com - Investing.com Nigeria
Outset Medical appoints Kevin O’Boyle to board of directors - TipRanks
Outset Medical (OM) Welcomes Kevin O'Boyle to Board, Dale E. Jon - GuruFocus
Outset Medical Appoints Kevin O’Boyle to Board - TipRanks
Outset Medical Appoints Industry Veteran Kevin O'Boyle to its Board of Directors - The Manila Times
Outset Medical adds healthcare veteran to board - Investing.com
Outset Medical (OM) Appoints Kevin O’Boyle to its Board - StreetInsider
Outset Medical Appoints Industry Veteran Kevin O’Boyle to its Board of Directors - GlobeNewswire
Former NuVasive CFO Kevin O'Boyle Joins Outset Medical Board, Bringing 20-Year Medical Device Expertise - Stock Titan
Does Outset Medical (NASDAQ:OM) Have A Healthy Balance Sheet? - simplywall.st
Outset Medical First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Outset Medical to Present at RBC Global Healthcare Conference - GlobeNewswire
Outset Medical (NASDAQ:OM) Trading 35.3% Higher Following Analyst Upgrade - Defense World
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Outset Medical, Inc. Investors to Inquire About Securities Class Action InvestigationOM - GuruFocus
Outset Medical to Present at RBC Global Healthcare Conference | OM Stock News - GuruFocus
Outset Medical To Present At RBC Global Healthcare Conference - Barchart.com
Outset Medical, Inc. Class Action: Levi & Korsinsky Reminds Outset Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – OM - ACCESS Newswire
Outset Medical, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
Investors who lost money on Outset Medical, Inc.(OM) should contact Levi & Korsinsky about pending Class ActionOM - ACCESS Newswire
Outset Medical, Inc. (NASDAQ:OM) Q1 2025 Earnings Call Transcript - Insider Monkey
Levi & Korsinsky Reminds Outset Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – OM - ACCESS Newswire
Outset Medical’s Positive Earnings Call Highlights Growth - TipRanks
Investors who Lost Money on Outset Medical, Inc. (OM) Should Contact Levi & Korsinsky About Pending Class ActionOM - ACCESS Newswire
Outset Medical (OM) Receives Target Price Increase from RBC Capital | OM Stock News - GuruFocus
Outset Medical stock holds as Oppenheimer maintains Perform rating By Investing.com - Investing.com Nigeria
Outset Medical (OM) Sees Price Target Increase Amid Growth | OM Stock News - GuruFocus
RBC Raises Price Target on Outset Medical to $14 From $12, Keeps Sector Perform Rating - marketscreener.com
Outset Medical stock holds as Oppenheimer maintains Perform rating - Investing.com
Oppenheimer Reiterates Perform Rating on Outset Medical Inc. (OM) - StreetInsider
Outset Medical Inc (OM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Outset Medical Inc (OM) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Sales Transformation - GuruFocus
Outset Medical Reports Strong Q1 Growth and Improved Margins - TipRanks
Earnings call transcript: Outset Medical Q1 2025 reveals wider EPS loss - Investing.com
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Outset Medical Inc. (OM) Misses Q1 EPS by 294c - StreetInsider
Outset Medical (OM) Maintains 2025 Financial Forecasts | OM Stock News - GuruFocus
Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined - The Manila Times
Outset Medical First-Quarter Results Demonstrate Strong - GlobeNewswire
Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue ... - Bluefield Daily Telegraph
Outset Medical Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
Shareholders That Lost Money on Outset Medical, Inc. (OM) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Levi & Korsinsky Announces an Investigation on Behalf of Outset Medical, Inc. (OM) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Finanzdaten der Outset Medical Inc-Aktie (OM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):